(Q36945978)

17 August 2017

1 reference

title

Strategies for enhanced photodynamic therapy effects (English)

1 reference

17 August 2017

Sarika Verma

1

1 reference

17 August 2017

Gregory M Watt

series ordinal

2

1 reference

17 August 2017

Zhiming Mai

series ordinal

3

1 reference

17 August 2017

Tayyaba Hasan

series ordinal

4

1 reference

17 August 2017

1 September 2007

1 reference

Photochemistry and Photobiology

17 August 2017

1 reference

17 August 2017

83

1 reference

17 August 2017

5

1 reference

17 August 2017

996-1005

1 reference

An update on photodynamic therapy applications

17 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Photodynamic therapy in dermatology: current concepts in the treatment of skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Fluence rate as a modulator of PDT mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Oxygen consumption and diffusion effects in photodynamic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Current clinical and preclinical photosensitizers for use in photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Photodynamic therapy (PDT) of malignant tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Analysis of photosensitivity in Japanese cancer-bearing patients receiving photodynamic therapy with porfimer sodium (Photofrin).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Photodynamic therapy: combined modality approaches targeting the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of fluence rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Mechanistic investigation and implications of photodynamic therapy induction of vascular endothelial growth factor in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

The matrix metalloproteinase inhibitor prinomastat enhances photodynamic therapy responsiveness in a mouse tumor model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

A mechanism-based combination therapy reduces local tumor growth and metastasis in an orthotopic model of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Differentiation enhances aminolevulinic acid-dependent photodynamic treatment of LNCaP prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Protease sensors for bioimaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Developing a peptide-based near-infrared molecular probe for protease sensing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Fluorescent probes for proteolysis: tools for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Cell-permeable near-infrared fluorogenic substrates for imaging beta-lactamase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Targeting enzymes for cancer therapy: old enzymes in new roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Antibody-directed enzyme prodrug therapy (ADEPT): a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

State of the art in the delivery of photosensitizers for photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Targeted photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

The effect of tissue and cellular pH on the selective biodistribution of porphyrin-type photochemotherapeutic agents: a volumetric titration study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

What does photodynamic therapy have to offer radiation oncologists (or their cancer patients)?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Photodynamic therapy with hypericin induces vascular damage and apoptosis in the RIF-1 mouse tumor model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Efficacy of antitumoral photodynamic therapy with hypericin: relationship between biodistribution and photodynamic effects in the RIF-1 mouse tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Foscan uptake and tissue distribution in relation to photodynamic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Verteporfin: a milestone in opthalmology and photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Photodynamic therapy with Pd-Bacteriopheophorbide (TOOKAD): successful in vivo treatment of human prostatic small cell carcinoma xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Combining vascular and cellular targeting regimens enhances the efficacy of photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Outcome of mTHPC mediated photodynamic therapy is primarily determined by the vascular response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Role of delivery vehicles for photosensitizers in the photodynamic therapy of tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Low-density lipoprotein receptors in the uptake of tumour photosensitizers by human and rat transformed fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Liposomal delivery of photosensitising agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Targeting of a hydrophilic photosensitizer by use of internalizing monoclonal antibodies: A new possibility for use in photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Selective targeting of cancer cells using synthetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Targeted photodynamic therapy via receptor mediated delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Photosensitizer targeting in photodynamic therapy. I. Conjugates of haematoporphyrin with albumin and transferrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Evidence for low-density lipoprotein receptor-mediated uptake of benzoporphyrin derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

The role of low-density lipoprotein receptors in sensitivity to killing by Photofrin-mediated photodynamic therapy in cultured human tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Photodynamic targeting of human retinoblastoma cells using covalent low-density lipoprotein conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Biodistribution of charged F(ab')2 photoimmunoconjugates in a xenograft model of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Pegylated polyethylenimine-Fab' antibody fragment conjugates for targeted gene delivery to human ovarian carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Photochemical targeting of epidermal growth factor receptor: a mechanistic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Photosensitizer-antibody conjugates for detection and therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Receptor-mediated targeting of a photosensitizer by its conjugation to gonadotropin-releasing hormone analogues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Antiangiogenic photodynamic therapy (PDT) by using long-circulating liposomes modified with peptide specific to angiogenic vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Nuclear targeting signal recognition: a key control point in nuclear transport?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Targeted intracellular delivery of photosensitizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Synthesis, characterization, and plasma lipoprotein association of a nucleus-targeted boronated porphyrin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Enhanced cellular uptake with a cobaltacarborane-porphyrin-HIV-1 Tat 48-60 conjugate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

In vivo selection of phage for the optical imaging of PC-3 human prostate carcinoma in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Solubilization of poorly soluble PDT agent, meso-tetraphenylporphin, in plain or immunotargeted PEG-PE micelles results in dramatically improved cancer cell killing in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

The phototoxicity of photofrin was enhanced by PEGylated liposome in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Preparation, characterization, photocytotoxicity assay of PLGA nanoparticles containing zinc (II) phthalocyanine for photodynamic therapy use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Encapsulation of porphyrins and chlorins in biodegradable nanoparticles: the effect of dye lipophilicity on the extravasation and the photothrombic activity. A comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Polymeric nanoparticle preparation that eradicates tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

New approaches to antibody therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

In vitro selection of RNA molecules that bind specific ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Pegaptanib sodium for the treatment of neovascular age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Discovery and development of anticancer aptamers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

RiboaptDB: a comprehensive database of ribozymes and aptamers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Direct in vitro selection of a 2'-O-methyl aptamer to VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

Vascular targeted nanoparticles for imaging and treatment of brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2007.00166.X

10.1111/J.1751-1097.2007.00166.X

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference